Trial
NCT01466725
A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Celgene
Collaborators
—
Condition
Discoid Lupus
Intervention
CC-930
Why stopped
The benefit/risk profile does not support continuation of this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-19